 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 2002, 22(24):10906-10913
Genetic Dissociation of Opiate Tolerance and Physical Dependence
in -Opioid Receptor-1 and Preproenkephalin Knock-Out Mice
Joshua F.
Nitsche1,
Alwin G. P.
Schuller1,
Michael A.
King2,
Min
Zengh1,
Gavril W.
Pasternak2, and
John E.
Pintar1
1 Department of Neuroscience and Cell Biology,
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson
Medical School, Piscataway, New Jersey 08854, and
2 Laboratory of Neuropharmacology, Memorial
Sloan-Kettering Cancer Center, New York, New York 10021
Previous experiments have shown that mice lacking a functional
-opioid receptor (DOR-1) gene do not develop
analgesic tolerance to morphine. Here we report that mice lacking a
functional gene for the endogenous ligand preproenkephalin
(ppENK) show a similar tolerance deficit. In
addition, we found that the DOR-1 and
ppENK knock-outs as well as the NMDA receptor-deficient
129S6 inbred mouse strain, which also lacks tolerance, exhibit
antagonist-induced opioid withdrawal. These data demonstrate that
although signaling pathways involving ppENK, DOR, and NMDA receptor are
necessary for the expression of morphine tolerance, other pathways
independent of these factors can mediate physical dependence. Moreover,
these studies illustrate that morphine tolerance can be genetically dissociated from physical dependence, and thus provide a genetic framework to assess more precisely the contribution of various cellular
and molecular changes that accompany morphine administration to these processes.
Key words:
morphine; opiate; µ-opioid receptor; -opioid
receptor; preproenkephalin; NMDA receptor; tolerance; dependence
Copyright © 2002 Society for Neuroscience 0270-6474/02/222410906-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
E. E. Codd, J. R. Carson, R. W. Colburn, S. L. Dax, D. Desai-Krieger, R. P. Martinez, L. A. McKown, L. A. Neilson, P. M. Pitis, P. L. Stahle, et al.
The Novel, Orally Active, Delta Opioid RWJ-394674 Is Biotransformed to the Potent Mu Opioid RWJ-413216
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
1273 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chung, S. Pohl, J. Zeng, O. Civelli, and R. K. Reinscheid
Endogenous Orphanin FQ/Nociceptin Is Involved in the Development of Morphine Tolerance
J. Pharmacol. Exp. Ther.,
July 1, 2006;
318(1):
262 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-S. Kim, K.-W. Lee, K.-W. Lee, J.-Y. Im, J. Y. Yoo, S.-W. Kim, J.-K. Lee, E. J. Nestler, and P.-L. Han
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action.
PNAS,
March 7, 2006;
103(10):
3908 - 3913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Walwyn, N. T. Maidment, M. Sanders, C. J. Evans, B. L. Kieffer, and T. G. Hales
Induction of {delta} Opioid Receptor Function by Up-Regulation of Membrane Receptors in Mouse Primary Afferent Neurons
Mol. Pharmacol.,
December 1, 2005;
68(6):
1688 - 1698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zuo
The Role of Opioid Receptor Internalization and {beta}-Arrestins in the Development of Opioid Tolerance
Anesth. Analg.,
September 1, 2005;
101(3):
728 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Roy, X. Guo, J. Kelschenbach, Y. Liu, and H. H. Loh
In Vivo Activation of a Mutant {micro}-Opioid Receptor by Naltrexone Produces a Potent Analgesic Effect But No Tolerance: Role of {micro}-Receptor Activation and {delta}-Receptor Blockade in Morphine Tolerance
J. Neurosci.,
March 23, 2005;
25(12):
3229 - 3233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen
Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Pharmacol. Rev.,
March 1, 2005;
57(1):
1 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Thompson, H. Wojno, E. Greiner, E. L. May, K. C. Rice, and D. E. Selley
Activation of G-Proteins by Morphine and Codeine Congeners: Insights to the Relevance of O- and N-Demethylated Metabolites at {micro}- and {delta}-Opioid Receptors
J. Pharmacol. Exp. Ther.,
February 1, 2004;
308(2):
547 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inoue, M. Mishina, and H. Ueda
Locus-Specific Rescue of GluR{epsilon}1 NMDA Receptors in Mutant Mice Identifies the Brain Regions Important for Morphine Tolerance and Dependence
J. Neurosci.,
July 23, 2003;
23(16):
6529 - 6536.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|